WO2005051314A3 - Iraks as modifiers of branching morphogenesis and methods of use - Google Patents
Iraks as modifiers of branching morphogenesis and methods of use Download PDFInfo
- Publication number
- WO2005051314A3 WO2005051314A3 PCT/US2004/039408 US2004039408W WO2005051314A3 WO 2005051314 A3 WO2005051314 A3 WO 2005051314A3 US 2004039408 W US2004039408 W US 2004039408W WO 2005051314 A3 WO2005051314 A3 WO 2005051314A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- branching morphogenesis
- methods
- iraks
- modifiers
- irak
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52455003P | 2003-11-24 | 2003-11-24 | |
US60/524,550 | 2003-11-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005051314A2 WO2005051314A2 (en) | 2005-06-09 |
WO2005051314A3 true WO2005051314A3 (en) | 2007-04-26 |
Family
ID=34632906
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/039790 WO2005052132A2 (en) | 2003-11-24 | 2004-11-22 | Mbms as modifiers of branching morphogenesis and methods of use |
PCT/US2004/039550 WO2005051320A2 (en) | 2003-11-24 | 2004-11-23 | Gcks as modifiers of branching morphogenesis and methods of use |
PCT/US2004/039408 WO2005051314A2 (en) | 2003-11-24 | 2004-11-23 | Iraks as modifiers of branching morphogenesis and methods of use |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/039790 WO2005052132A2 (en) | 2003-11-24 | 2004-11-22 | Mbms as modifiers of branching morphogenesis and methods of use |
PCT/US2004/039550 WO2005051320A2 (en) | 2003-11-24 | 2004-11-23 | Gcks as modifiers of branching morphogenesis and methods of use |
Country Status (1)
Country | Link |
---|---|
WO (3) | WO2005052132A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0809069D0 (en) | 2008-05-19 | 2008-06-25 | Univ Leuven Kath | Gene signatures |
UY31830A (en) | 2008-05-16 | 2010-01-05 | Takeda Pharmaceutical | GLUCOQUINASE ACTIVATORS |
CA2749180C (en) * | 2009-01-07 | 2017-03-21 | Haidong Huang | Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992018641A1 (en) * | 1991-04-10 | 1992-10-29 | The Trustees Of Boston University | Interleukin-8 receptors and related molecules and methods |
WO1997000690A1 (en) * | 1995-06-23 | 1997-01-09 | Tularik, Inc. | Interleukin-1 receptor-associated protein kinase and assays |
US5654397A (en) * | 1985-06-23 | 1997-08-05 | Tularik, Inc. | Interleukin-1 receptor-associated protein kinase and assays |
US20020192695A1 (en) * | 2001-06-05 | 2002-12-19 | Lori Friedman | PIBs as modifiers of the p53 pathway and methods of use |
US20030059916A1 (en) * | 2000-01-13 | 2003-03-27 | Holger Wesche | IRAK-4: compositions and methods of use |
US20030064917A1 (en) * | 1998-07-23 | 2003-04-03 | Crawford Susan E. | Methods and compositions for inhibiting angiogenesis |
US20030100005A1 (en) * | 2001-11-26 | 2003-05-29 | Karim Felix D. | CRBs as modifiers of branching morphogenesis and methods of use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020026037A1 (en) * | 1995-06-06 | 2002-02-28 | Jing-Shan Hu | Vascular endothelial growth factor 3 antibodies |
US6365356B1 (en) * | 1999-03-17 | 2002-04-02 | Cornell Research Foundation, Inc. | Receptors that regulate cell signaling relating to chemokines |
-
2004
- 2004-11-22 WO PCT/US2004/039790 patent/WO2005052132A2/en active Application Filing
- 2004-11-23 WO PCT/US2004/039550 patent/WO2005051320A2/en active Application Filing
- 2004-11-23 WO PCT/US2004/039408 patent/WO2005051314A2/en active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5654397A (en) * | 1985-06-23 | 1997-08-05 | Tularik, Inc. | Interleukin-1 receptor-associated protein kinase and assays |
WO1992018641A1 (en) * | 1991-04-10 | 1992-10-29 | The Trustees Of Boston University | Interleukin-8 receptors and related molecules and methods |
WO1997000690A1 (en) * | 1995-06-23 | 1997-01-09 | Tularik, Inc. | Interleukin-1 receptor-associated protein kinase and assays |
US20030064917A1 (en) * | 1998-07-23 | 2003-04-03 | Crawford Susan E. | Methods and compositions for inhibiting angiogenesis |
US20030059916A1 (en) * | 2000-01-13 | 2003-03-27 | Holger Wesche | IRAK-4: compositions and methods of use |
US20020192695A1 (en) * | 2001-06-05 | 2002-12-19 | Lori Friedman | PIBs as modifiers of the p53 pathway and methods of use |
US20030100005A1 (en) * | 2001-11-26 | 2003-05-29 | Karim Felix D. | CRBs as modifiers of branching morphogenesis and methods of use |
Non-Patent Citations (1)
Title |
---|
AURON P.E.: "The interleukin 1 receptor: ligand interactions and signal transduction", CYTOKINE & GROWTH FACTOR REVIEWS, vol. 9, no. 3/4, 1998, pages 221 - 237, XP003010748 * |
Also Published As
Publication number | Publication date |
---|---|
WO2005052132A2 (en) | 2005-06-09 |
WO2005052132A3 (en) | 2007-06-07 |
WO2005051320A2 (en) | 2005-06-09 |
WO2005051314A2 (en) | 2005-06-09 |
WO2005051320A3 (en) | 2006-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007002080A3 (en) | Eya2s as modifiers of the pten/akt pathway and methods of use | |
WO2003045321A3 (en) | MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE | |
WO2003006614A3 (en) | UBE2s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
WO2006009962A3 (en) | Acacs as modifiers of the igf pathway and methods of use | |
WO2005016287A3 (en) | Prkwnks as modifiers of the rac pathway and methods of use | |
WO2004038371A3 (en) | Ccr8 as modifier of branching morphogenesis and methods of use | |
WO2005002418A3 (en) | Mptens as modifiers of the pten/igf pathway and methods of use | |
WO2005051314A3 (en) | Iraks as modifiers of branching morphogenesis and methods of use | |
WO2004066948A3 (en) | Mapcaxs as modifiers of the apc and axin pathways and methods of use | |
WO2005003297A3 (en) | Mptens as modifiers of the pten/igf pathway and methods of use | |
WO2004024882A3 (en) | FLJ20647s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
WO2005090992A3 (en) | Mptens as modifiers of the pten pathway and methods of use | |
WO2005072470A3 (en) | Mbms as modifiers of branching morphogenesis and methods of use | |
WO2004005483A3 (en) | ADCY3S AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
WO2004037990A3 (en) | MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE | |
WO2004005484A3 (en) | Snrks as modifiers of chk and branching morphogenesis and methods of use | |
WO2005017123A3 (en) | Mptens as modifiers of the pten pathway and methods of use | |
WO2003045314A3 (en) | Mhyps as modifiers of branching morphogenesis and methods of use | |
WO2005003303A3 (en) | Nadks as modifiers of branching morphogenesis and methods of use | |
WO2004014301A3 (en) | PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE | |
WO2004015071A3 (en) | CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE | |
WO2004048538A3 (en) | Csnks as modifiers of the rac pathway and methods of use | |
WO2004005486A3 (en) | Mp21s as modifiers of the p21 pathway and methods of use | |
WO2004024891A3 (en) | MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE | |
WO2005001026A3 (en) | Adks as modifiers of the pten pathway and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |